Iradimed Corp (OQ:IRMD)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for IRMD within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 17th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 12/20 Waldman Louis S. Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 8,750  
Feb 14/20 Feb 12/20 Waldman Louis S. Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 17,500  
Feb 14/20 Feb 12/20 Waldman Louis S. Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 8,750  
Feb 14/20 Feb 12/20 Waldman Louis S. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 8,750 $1.48
Feb 14/20 Feb 12/20 Waldman Louis S. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 17,500 $1.29
Feb 14/20 Feb 12/20 Waldman Louis S. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 8,750 $1.29
Feb 14/20 Feb 12/20 Waldman Louis S. Direct Ownership Common Stock S - Open market or private sale -4,307 $25.48
Jan 14/20 Jan 10/20 Johnson Brent Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -5,000  
Jan 14/20 Jan 10/20 Johnson Brent Direct Ownership Common Stock S - Open market or private sale -5,000 $25.30
Jan 14/20 Jan 10/20 Johnson Brent Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 5,000 $0.930
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for IRMD within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 17th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 12/20 Waldman Louis S. Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 8,750  
Feb 14/20 Feb 12/20 Waldman Louis S. Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 17,500  
Feb 14/20 Feb 12/20 Waldman Louis S. Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 8,750  
Feb 14/20 Feb 12/20 Waldman Louis S. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 8,750 $1.48
Feb 14/20 Feb 12/20 Waldman Louis S. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 17,500 $1.29
Feb 14/20 Feb 12/20 Waldman Louis S. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 8,750 $1.29
Feb 14/20 Feb 12/20 Waldman Louis S. Direct Ownership Common Stock S - Open market or private sale -4,307 $25.48
Jan 14/20 Jan 10/20 Johnson Brent Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -5,000  
Jan 14/20 Jan 10/20 Johnson Brent Direct Ownership Common Stock S - Open market or private sale -5,000 $25.30
Jan 14/20 Jan 10/20 Johnson Brent Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 5,000 $0.930
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $IRMD

Competitors

Competitors with Recent Insider Filings
Novocure (OQ:NVCR)
Shockwave Medical (OQ:SWAV)
Abbott Laboratories (N:ABT)